Placenta Development Study
| Status: | Recruiting |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/5/2018 |
| Start Date: | April 17, 2018 |
| End Date: | March 2019 |
| Contact: | Jill A Harsch, BS |
| Email: | acncstudies@archilrens.org |
| Phone: | 501-364-3309 |
Epigenetic Mechanisms Underlying Trophoblast Syncytialization
This study will help us learn more about how the placenta develops.
The primary purpose of this study is to understand the epigenetic signaling events in
placental trophoblast development.
placental trophoblast development.
Inclusion Criteria:
- BMI - 18-25 kg/m2
- at least 18 years of age
- singleton pregnancy
- less than 36 weeks and plan to deliver in the Little Rock/North Little Rock Area
Exclusion Criteria:
- Women with pre-existing medical conditions (e.g. diabetes, hypertension,
pre-eclampsia, STD, gestational diabetes)
- Women who are using recreational drugs, tobacco, or alcohol during their pregnancy.
- Women who plan on keeping their placenta following delivery for non-medical reasons.
We found this trial at
1
site
Little Rock, Arkansas 72202
Principal Investigator: Kartik Shankar, PhD
Phone: 501-364-3309
Click here to add this to my saved trials
